This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Daisuke Takahashi, PhD
Executive Specialist at Ajinomoto Co. Inc.
Speaker

Profile

He graduated from Nihon University and earned his Ph.D. from Gifu Pharmaceutical University in 2012. After joining AJINOMOTO Co., Inc., he worked as a process chemist specializing in amino acids and nucleosides derivatives, heterocyclic chemistry. To date, he has published over 10 scientific papers and applied more than 50 patents. He began his research in peptide chemistry in 2005 and is the originator of AJIPHASE® technology, which combines the strengths of both solid-phase and liquid-phase chemistry for peptides and oligonucleotides. He was awarded the International Symposium on Process Chemistry Award in 2011. Currently, he oversees technology in peptide and oligonucleotide chemistry at AJINOMOTO.

Agenda Sessions

  • Pioneering Enzymatic siRNA Manufacturing at Large Scale: A Cost-Effective Hybrid Approach with Solution Phase Synthesis

    12:20pm